RBVRR WOMEN'S COLLEGE OF PHARMACY

3-4-343, Barkathpura, Hyderabad - 500027, Ph: 040-27563065

Pharmaceutical Chemistry

PHARMACY PHARMACEUTICAL CHEMISTRY PROJECT TITLES

2010 – 2012

R.No.

Name of the Student

Title of the Books

1-001

S.P.Anupama

Synthesis and Docking studies of novel series of Pyridazine (.1-c) (1,2,4) Triazines

2-002

Lateef Unnisa

Development of Industrial Proces for N-Methyl Pyridine -2- Aldoxime Salts of Pharmaceutical Importance

3- 003

P.Megha

A Novel Synthesis, Characterization And Docking Studies of 2-Thio-Substituted Benzo(d) Thiazole Derivatives

4-004

K.Rama

A Project Report on “Synthesis, Characterisation and Docking studies of some novel series of 7-(O-Triazolo pyridazin -3yl)-4- methyl coumarins”.

 5-005

N.Mounika

Synthesis, Characterization and Docking Studies of Novel Series of 2-Substitued – 6- arylpyridazin-3(2H)- Ones as Dopaminergic agents.

6-006

A.Sravya

Synthesis and Docking Studies of Novel 2- Substituted -6- Arylpyridazine -3(2H)-Ones as 5HT2A Antagonists.

7-007

M.Sukanya

Synthesis, Characterisation and Anti Bacterial Activity of Mannich Bases of Coumarins.

8-008

N.S.P. Sirisha

Synthesis, Docking Studies and invitro CytotoxicEvaluation of Novel 4—(benzo(d) thiazol-2-yl)-N-Phenylaniline derivatives.

 9-009

P.Spoorthi

Synthesis and Docking Studies of 3,7- Disubstituted-Pyridazin(8,1-c) (1,2,4) Triazines As Novel PDE-4 Inhibitors.

10-010

T.Vinayalaxmi

Synthesis, Characterization and Docking Studies of Novel 6-Aryl 2- (Piperidin-1-yl/pyrrolidin-1-yl) Bensothiazole Derivatives.

11-011

P.Saritha

Synthesis, Charcterization and Docking Studies of Novel Series of 2-(5(1H)- Tetrazolo)-YL-6-ARYL-4,5-Dihydro/Dehydro-Pyridazin-3(2H)-Ones.

12-012

P.V.Nageswari

Synthesis, Characterization and Biological Evaluation of a Series of Schiff’s Bases of 2-(2-OXO-ARYL) Ehyl Pyridazin=3-Thiones.

13-013

K.Suneetha

Synthesis, Characterization and Biological Ebaluation of Novel 1,2,3-TRI-Substituted Indoles.

14-014

Poonam Chakravarthy

Homology Moderling and Validation of Human FGFR4-Tyrosine Kinase domain using Structure based Studies.

15-015

K.Rajitha

Molecular Docking and Virtual Screening for Novel inhibitors of Protein tyrosine phosphates 1B (PTP1B).

16-016

K.Sailaja

In-Silico Screening of Inhibitors for the Human Siah 2, Implications for Hypoxia- Induced Cancers.

2011 – 2013

R.No.

Name of the Student

Title of the Books

1-001

K.Geetha Reddy

Synthesis, Characterization, Docking Studies and Biological Evaluation of Some Novel 2,4,5,6 Tetra Substituted Pyridazin =3(2H) Ones.

2-002

K.P.Sunitha

Optimization, Characterization of Imputly Profile of Telmisartan By Improved Synthetic Activity of Impurity (Chloro Analog).

3-003

V. Tejaswini

Synthesis, Characterization, Docking Studies And Biological Ebaluation of Some Novel Mannich Bases of Pyridazin-3(2H)-Thione Derivatives.

4-004

N.Swetha

Synthesis, Characterization, Docking Studies And Biological Evaluation of Some Novel Pyrimido (4,5-c) Pyridazines.

5-005

D. Sai Sudha

Synthesis, Characterization and Docking Studies and Novel Seies of Pyridazinone Substituted Benzene Sulfonylureas.

6-006

S.Srujana

Synthesis, Characterization, Docking Studies and Biological Evaluation of Some Novel Sulfamoyl Phenyl Peridazinone.

7-007

R.Sumala

Synthesis, Charcterization and In-Silico Evaluation of Novel Phthalazine Derivatives as Antihypertensive Agents.

8-008

P.Spandana

Synthesis, Characterization, Docking Studies And Biological Ebaluation of Some Novel 4-Pyrazolyl Substituted  Pyridazin -3(2H)- Ones.

2012 – 2014

R.No.

Name of the Student

Title of the Books

1-001

Priyanka Reddy. Vangala

Insilico Screening of Novel HSP90 Inhibitors Based on Imidiaso Pyrimidines / Bensimidazoles Substituted Derivatives by 3DQSAR And Docking.

2-002

Preethi. B

Homology Modeling of Stat3 Protein And Virtual Screening of Stat3 Inhibitors Based on Tetrazole / Quinazolin/ Thiophene Substituted Amides by Docking And 3DQSAR Studies.

3- 004

Amreen Begum

3DQSAR, Docking And Adme Studies of Novel 1,2 Bensisothiazol 3(2H)-One, Oxidiazole & Other Hybrid Derivatives As Potent Inhibitors of Dengue Virus NS2B/NS3.

4-005

Mounika , Morampudi

Virtual Screening of JAK2 Inhibitors Based on Pyrrolotriazines/ Triazolopyridines by 3DQSAR And Docking.

 5-006

Sri Vidya , Chitukula

Homology Modeling of Transient Receptor Potential Vanilliod, (TRPV1) And Insilico Screening of Novel TRPV1 Inhibitors Based on Diarylpentadienamide Derivatives By 3D-QSAR And Docking Studies.

6-007

Haritha, Somavar

In Silico Screening of H-Imidazo(4,5-B) PYRIDIN-2(3H)- Onederivatives As Novel Inhibitors of B Rafkinase By 3DQSAR And Docking Studies.

7-009

Vamshi Priya, N

Virtual Screening of Novel Rho Kinase Inhibitors Based on Pyrazole Substituted Benzamides / Quinazolines And Other Amides By 3D QSAR And Docking Studies.

8-010

Madeni Ayesha

In Silico Screening of Novel Inhibitors of 5-LOX Based On Naphthyl Prinixic Acid/Indole Derivatives By 3D QSAR And Docking Studies.

 9-011

Mounika, Are

Molecular Modeling of Indolinone Derivatives As Transforming Growth Factor Beta Receptori (TGFBR1) Inhibitors By 3D QSAR And Docking Studies Based On fused Nitrogen Containing Heterocycles.

 2013 – 2015

   R.No.

Name of the Student

Title of the Books

1-001

2013-15

M.Kavitha

Roll.No.170613884001

Isolation, Characterization of phytochemical constituents and pharmacological investigation of Cissus vitiginea leaves.

2014- 2016

R.No.

Name of the Student

Title of the Books

1-012

S. Namitha

Molecular docking Pharmacophore Mapping and admet studies of Benzimidazole derivatives as inhi- bitors of Human Cyclin Dependent Kinase 2 enzyme.

2016-2018 

R.No.

Name of the Student

Project Titles

1-001

Sadiya Fatima

Roll. No:1706-16-884-001

synthesis, characterization and biological evaluation of 2-hydroxy-2-methyl-6-arys-2-3-dihyro-7h-[1,3] thiazolo [3,2-b] [pyridazine.

2-004

Haleema Zainab Begum

Roll. No:1706-16-884-004

Synthesis, Characterization, Biological activity of Some Novel Mannich Bases of Pyridazine -3(2H)- Ones Derivatives.

2017-2019 

R.No.

Name of the Student

Project Titles

1-001

A. Monalika

Roll. No:1706-17-884-001

Design Molecular Docking Synthesis And Biological Evaluation of Novel 2,5-Substituted Imidazole Derivatives As Anti-Inflammatory Agents.

2-002

Akula Akhila Sai

Roll. No:1706-17-884-002

Design Molecular Docking Synthesis Biological Evaluation of 4,5-Substituted 1,2,3-Triazoles As Antibacterial Agents.

3-003

Ayesha Begum

Roll.No:1706-17-884-003

Isolation And Characterization of Phytochemicals From Leaves of Cissus Pallida.

4-004

B. Naga Jyothi

Roll.No:1706-17-884-004

Synthesis Molecular Docking And Anti-Diabetic Evaluation of Some New Sulphonamido Substituted Imidazolone Derivatives.

5-005

 

P. Shravani

Roll.No:1706-17-884-005

Synthesis Molecular Docking, and Anti Bacterial Activity of Some New 3-Sulphonamido Substituted Quinazolinone Derivatives.

 2016-2019

R.No.

Name of the Student

Project Titles

1-002

Jadi Amani Rani

Roll. No:1706-16-884-002

Synthesis, Characterization And Biological Evaluation Series of Schiffs Bases of 2-(2-OXO-2-Methyl)-Propyl 6-Aryl- 4,5-Dihydro Pyridazine-3-Thiones.

2018-2020

S.No.

Name of the Student

Project Titles

4002

Syeda Advia Sanobar

Structure Based Virtual Screening, Design, Synthesis, And Biological Evaluation Of 3-Sulfonamido Substituted Quinazolinones As Anti- Zika Viral Agents

4004

Zaberunnisa

Synthesis, Characterization, Molecular Docking And Biological Evaluation Of N-(Benzyloxy)-1h-Indole-2- Carboxamide Derivatives

4005

K. Sreelatha

Structure Based Virtual Screening, Design, Synthesis And Biological Evaluation Of Imidazoles As Antidiabetic Agents

4006

Nagma Begum

Synthesis, Characterization, Molecular Docking And Biological Evaluation Of 6-Methoxy-Benzothiazol-2-Yl-Amide Derivatives

 2019-2021

   S.No.

Name of the Student

Title of the Books

1-001

Guide:

Meher Unnisa

Roll.No.170619884001

Dr.K.Sruthi

Insilico Approaches for the Design and Synthesis of N-Substituted Imidazolyl Amido Coumarin Derivatives as new dual mPGES-1/5-Lo Inhibitors.

2-002

Guide:

M.Maneesha

Roll.No.170619884002

Dr.K.Sruthi

Insilico Approaches for the design and synthesis of potent istatin sulfonamide as alphaglucosidase inhibitors implicated in treatment of diabetes.

3- 003

2018-21

Guide:

Nagaram Pranaya

Roll.No.170618884003

Dr.M.Vijaya Bhargavi

Structure based virtual screening , design, synthesis, biological evaluation of indole derivatives as respiratory syncytial virusfusion (RSV-F) inhibitors.

 2020—2022

   S.No.

Name of the Student

Title of the Books

1-001

Guide:

Palmoni Manisha

Roll.No.170620884001

Dr.M.VijayaBhargavi

QSAR-Based Virtual screening, Molecular Docking , Synthesis, and Biological Evaluation of Coumarin ad 1,3,4-Oxadiazole Hybrids as Anticancer Agents.

2-002

Guide:

Thoka Shirisha

Roll.No.170618884001

Dr.M.VijayaBhargavi

    (2018- 2021)

Structure Based Virtual Screening, Design, Synthesis and Biological Evaluation of Coumarin-Benzothiazole Hybrid Derivatives as INHA ( Enoyl acyl carrier protein reductase) Inhibitors in the Treatment of Tuberculosis.

 2021—2023

   S.No.

Name of the Student

Title of the Books

1-001

Guide:

Mameena Sahoo

Roll.No.170621884001

Dr.M.VijayaBhargavi

Structure Based Virtual Screening, Molecular Docking, Syntheses and Biological Evaluation of Benzothiazole and 1,2,4- Oxadiazole Hybrids as oral antidiabetic agents

2-002

Guide:

Shafia Sultana

Roll.No.170621884002

Dr..M.VijayaBhargavi

Qsar Based virtual screening, Molecular Docking, Sythesis and Biological evaluation olf Indole and Quinazolinone hybrid derivatives as P13K inhibitors for the treatment of cances.

3-003

Guide:

Shahista Begum

Roll.No.170621884003

Dr..M.VijayaBhargavi

Structure – based virtual screening, molecular docking, synthesis and biological evaluation of 1,3,4- oxadiazole and 1,2,4- Triazole derivaties as antibacterial agents.

2016-2020

B.Pharmacy (CBCS) Mini Project Titles

 

S.No.

 

 

Roll no.

Name of the Student & Guide

 

Project Title

1

31

K. Mounika

Dr. M. Vijaya Bhargavi

Synthesis, characterisation of 7-Substituted-4-Methyl coumarin derivatives as anti-inflammatory agents.

2

84

S. Vagdevi

Dr. M. Vijaya Bhargavi

Ligand based virtual screening of coumarin derivatives as NHE (Na+/H+ exchange) inhibitors for the treatment of cancer

3

80, 77

Syeda rabab Fatima & k. Sushma

Dr. K. Sruthi

Mechanochemical synthesis of novel-4-arylidine oxazolone derivatives

4

83

Usha Shalini

Dr. K. Sruthi

Ligand based virtual screening of pyrimidine derivatives in the treatment of NIPAH virus infections

5

59

Sai bhavani

Mrs. V. Padmaja

Design and virtual screening of pyrimidine derivatives as potent anticancer agents. 

6

28

G. Manasa

Mrs.S.P.Anupama

Design and virtual screening of novel inhibitors of NS2B-NS3 protease in the treatment of Dengue viral infections

7

16

V. Chandrika

Mrs. P. Archana

Design and virtual screening of Quinoline derivatives as InhA (enoyl acyl carrier protein reductase) inhibitors for the treatment of tuberculosis

8

87

Vindyasree

Mrs. Padma Bhavani

Design and virtual screening of beta carboline derivatives as potent anticancer agents

  B PHARMACY PROJECTS (2017-21)

 

S.No.

 

 

Roll no.

Name of the Student & Guide

 

Project Title

1

170617881054

170617881056

170617881057

170617881099

170617881100

 

LokaShivani

Manchella Sai Supriya

MangaliMamatha

SukkaDivija

VarriNishitha

Dr. M. Vijaya Bhargavi

Virtual screening, molecular docking and drug likeliness prediction of Pyramidine containing heterocyles as JAK 2 inhibitors for the treatment of RA

2

170617881048

170617881020

170617881002

170617881004

170617881024

Kavya Reddy

Chavidi Sreejani

A.Sripriya

Agalduty Neha

Dharmula Samatha

Dr. K. Sruthi

Active site prediction, Virtual screening and molecular docking studies for ligands of some orphan receptors

B PHARMACY PROJECTS (2018-22)

 

S.No.

 

 

Roll no.

Name of the Student & Guide

 

Project Title

1

170618881052

170618881062

170618881064

170618881080

170618881099

D.Preethi Laya

K.Rithika

T.Sai sankeerthana

C.Srija
K.Supriya

 

Dr. M. Vijaya Bhargavi

Structure based virtual screening, 

molecular docking of Coumarin

 derivatives as BACE I inhibitors

 for the treatment of Alzheimers disease.

 

2

170618881059

170618881061

170618881073

170618881076

170618881078

D.Rani

V.Ravali

D.V.Shruthi

N.Spandana

K.Sravanthi

Dr. K. Sruthi

Insilico studies of various plant derived bioactive compounds as SARS COV2 Protease Inhibitors.

B PHARMACY PROJECTS (2019-23)

 

S.No.

 

 

Roll no.

Name of the Student & Guide

 

Project Title

1

170619881045

170619881069

170619881073

170619881074

170619881085

M.Raghavi

Ria Singh

Shaik samreen

Sheri Meghana

T.Gowthami

Prof.M.Sumakanth

Design and development of 3D QSAR model for Antidepressants

2

170619881044

170619881046

170619881058

170619881064

170619881065

M.Harshita Singh

M.Samyuktha

N.Spandana

P.Pooja

P.Anusha

Dr. M. Vijaya Bhargavi

Design and development of 3D QSAR model for Anti- Hyperlipedemics

3

170619881015

170619881049

170619881053

170619881057

170619881062

B.Sriharshini

M.Laxmi priya

M.Srividya

N. Sirisha

P.Sriharsha

Design and development of 3D QSAR model for NSAIDS

Publications

    1. Anti Cancer Activity of Naturally Occurring Heterocyclic Compounds,Shafia Sultana,Pilli Archana, Dr. M. Vijaya Bhargavi,  International Journal of Science and Research (IJSR)Volume 12 Issue 4, April 2023, 195-200.
    2. NOVEL THERAPIES FOR THE TREATMENT OF BREAST CANCER, Shahista Begum, Mameena Sahoo, Dr. M. Vijaya Bhargavi, Prof. Mogili.Sumakanth, Journal of Emerging Technologies and Innovative Research, April 2023, Volume 10, Issue 4, 244-255.
    3. THIAZOLIDINEDIONE AND NON-THIAZOLIDINEDIONES AS PPAR GAMMA AGONISTS, Mameena sahoo, Shahista Begum, Dr. M. Vijaya Bhargavi, Prof. M. Sumakanth, International Journal of Research and Analytical Reviews, April 2023, Volume 10, Issue 2, 483-492.
    4. Newer approaches on rDNA technology in vaccine development, International Journal of Novel Research and Development, Keerthana g , Dr M Vijay bhargavi, Volume 8, issue 12 December
    1. HDAC Inhibitors in Cancer Therapy: Harnessing Epigenetic Modifications in Targeted Treatment, Chencharam Tulasi , Dr. M. Vijaya Bhargavi, International Journal of All Research Education and Scientific Methods, ISSN: 2455-6211, Volume 11, Issue 12, December-2023.
    2. Soluble Guanylate Cyclase Stimulators in Heart Failure, Nida Mirza, Dr. M. Vijaya Bhargavi, International Journal of Science and Research, ISSN: 2319-7064, SJIF (2022): 7.942, Volume 12 Issue 12, December 2023.
    1. Newer approaches on rDNA technology in vaccine development, International Journal of Novel Research and Development, Keerthana g , Dr M Vijay bhargavi, Volume 8, issue 12 December 2023.
    2. Novel Therapies For The Treatment of Breast Cancer, Mogili.Sumakanth Shahista Begum, Mameena Sahoo, Dr. M. Vijaya Bhargavi, April 2023, Journal of Emerging Technologies and Innovative Research (JETIR), Volume10, Issue 4, 244-255. (7.95)
    1. Thiazolidinedione And Non Thiazolidinedione As PPAR Gamma Agonists, M. Sumakanth, Mameena sahoo , Shahista Begum , Dr. M. Vijaya Bhargavi, April 2023, International Journal of Research and Analytical Reviews (IJRAR), Volume 10, Issue 2, 483-492. (7.17)
    2. Anti Cancer Activity of Naturally Occurring Heterocyclic Compounds, Dr. M. Vijaya Bhargavi Shafia Sultana , Pilli Archana, April 2023, International Journal of Science and Research, Volume 12, Issue 4, 195-200. (7.5 impact factor)
    3. Role of Fat Metabolism in Gastric Cancer, A.Shafia Sultana B, Dr. M. Vijaya Bhargavi, C. Prof. M. Sumakanth October 2022, IJIRT, Volume 9 Issue 5, 605-610. (CIF – 4.36)
    4. Structure-Based Virtual Screening, Design,Synthesis And Biological Evaluation of Indole Derivatives as Respiratory Syncytial Virus Fusion (RSV-F) Inhibitors, M.vijaya bhargavi and Dr. M. Sumakanth Polamoni Manisha, Nagaram Pranaya, World Journal of Pharmaceutical Research December 2022, Volume 11, Issue 17, 809-824. (ICV-90.8)
    5. Structure-Based Virtual Screening, Design,Synthesis And Biological Evaluation Of Coumarin-Benzothiazole Hybrid Derivatives as Inha (Enoyl Acyl Carrier Protein Reductase) Inhibitors in The Treatment Of Tuberculosis. Polamoni Manisha, Thota Shirsha, Dr. M.Vijaya Bhargavi, Dr. M Sumakanth, International Journal for Research Trends and Innovation, 2022, IJRTI | Volume 7, Issue 9 | 2456-331
    6. Phase Transfer Catalysts, Polamoni Manisha , Dr. M Vijaya bhargavi, Journal of Emerging Technologies and Innovative Research 9 (4), 515-527, 2022
    7. HYPERTROPHIC CARDIOMYOPATHY, M. VijayaBhargavi, P. Soni Dixitha, International Journal of Pharmaceutical Sciences and Research 13 (8), 3043-3055, 2022.
    8. Design, Molecular Docking, Synthesis and Biological Evaluation of 4, 5-Substituted 1, 2, 3-Triazoles as Anti-bacterial Agents MSZU M. Vijayabhargavi, M. P. Kusuma, Akhila Sai, International Journal of Pharmaceutical Sciences and Nanotechnology, vol 14, Issue 2, 5372-5385, 2021. (0.5, scopus)
    9. A review article of SGLT2 inhibitors for the treatment of diabetes and obesity, PDMS P. Soni Dixitha, Dr.M. Vijaya Bhargavi, Journal of Pharmaceutical Sciences and Research 13 (11), 640-648, 2021. (Scimago Journal)
    10. “Synthesis, Characterization, Molecular Docking and Biological Evaluation of N- (Benzyloxy)-1H-Indole-2-Carboxamide Derivatives” zaber Unnisa, M. Vijaya bhargavi, M.Sumakanth, International Journal of All Research Education and Scientific Methods, 2020, vol 8, issue12, 661-686. (7.429)
    11. Synthesis, Characterization, Molecular Docking and Biological Evaluation of 6- Methoxy-Benzothiazol-2-Yl-Amide Derivatives, Vijaya bhargavi, Nagma begum, M.Sumakanth, 8-11-2020, INTERNATIONAL JOURNAL OF INNOVATIVE RESEARCH IN TECHNOLOGY, vol 7, issue6, 111-122. (sjif 7.37),
    12. A REVIEW ON BIOSIMILARS , Nagma Begum and Dr. M. Sumakanth Zaberunnisa, Dr. M. Vijaya Bhargavi, 2020, European Journal of Biomedical and Pharmaceutical Sciences, vol 7, issue 5, 669-678. (6.04)
    13. “Recent advances in antibiotic hybrids” zaber Unnisa, M. Vijaya bhargavi, Nagma begum, M.Sumakanth, International Journal of Pharmaceutical Sciences and Nanotechnology, 2020, vol13, issue3.(0.5, scopus)
    14. “Design, Molecular Docking, Synthesis And Biological Evaluation Of Novel 2,5-Substituted Imidazole Derivatives As Anti-Inflammatory Agents” Akepogu Monalika and M Vijaya Bhargavi, International Journal of Pharma and Bio Sciences, 2020; doi 10.22376/ijpbs.2020.11.1.p13-27. (Elsevier, 0.8)
    15. A New strategy for bacterial Resistance-Efflux Pump inhibitors” Nagma Begum, M. Vijaya   bhargavi, M.Sumakanth, International Journal of Emerging Technologies and Innovative Research Vol.6, Issue 6, Page no. 477-491, June 2019. 
    16. Synthesis, Molecular Docking, Analgesic, and Anti-Inflammatory Activities of New 1,2,4- Oxadiazolo-Sulfonamides Vijaya Bhargavi, P. Shashikala,  M. Sumakanth, C. Krishna, 2018.   RussianJournal of General Chemistry, 88(4), pp 804-811. ( Impact factor – 0.553).
    17. Synthesis, Molecular Docking and Biological Evaluation of Novel N-(Benzyloxy)-6- Fluro- Chromone-2-Carboxamides and N-(Benzyloxy)-Chromone-3-Carboxamides as Analgesic and Anti-inflammatory Agents, Der Pharmachemica, M VijayaBhargavi ,P Shashikala, MSumakanth and J Archana, 2018, 10        (5) ( Impact factor  – 0.4).

        26.    Design, Synthesis, and Cytotoxicity of Semisynthetic Betulinic Acid-1,  2, 4-Oxadiazole Amide Derivatives. Krishna, C., Bhargavi, M.V. and Krupadanam, G.L.D., 2018. Russian Journal of General Chemistry88(2), pp.312-318.( Impact factor – 0.553).

    27.     Design, Synthesis, Molecular Docking and Biological Evaluation of Novel Coumarin-oxime  Ether   Derivatives as COX-2 Inhibitors, 2017, M. Vijaya Bhargavi,P. Shashikala, M.Sumakanth, Shravan        Kumar. Gunda, Asian journal of chemistry, vol 29, No.11, 2559-2564.  ( Impact factor – 0.15).

    1. Coumarins and Chromones : A Remarkable Scaffolds for Anti-inflammatory Activity, 2017, Vijaya Bhargavi M, Shashikala P, Sumakanth M,  Pharm. Sci. & Res. Vol. 9(9), 1483-1489.( Impact factor – 0.59).
    2. Facile Regioselective Synthesis and Antimicrobial Activity of Novel 8-Isoxazolinyl   Coumarins via Nitrile Oxide Cycloaddition Approach Challa Krishna, Vijaya Bhargavi and G.L.     David Krupadanam, 2017, Asian Journal of organic & medicinal chemistry, 2(4),  pp.149-155.
    3. Synthesis of pyranoisoxazoline/isoxazole annulated coumarins via intramolecular nitrile oxide   cycloaddition and their  Krishna, C., Bhargavi, M.V., Rao, Y.J. andKrupadanam,   G.L.D., 2017. Russian Journal of General Chemistry87(8), pp.1857-1863.( Impact factor – 0.553). 
    4. Design, synthesis and antimicrobial activity of benzyl hydroxamic acid analogues of coumarin Challa Krishna, M Vijaya Bhargavi, G L David Krupadanam,Heterocyclic Letters Vol. 7| No.3|671-     682|May-July| 2017.( SJIF impact factor =3.833).
    5. A Comparative study of Myrosinase Activity in selected Cruciferous Vegetables after Conventional Heat and Microwave Treatments, International Journal of Current Research, Kusuma,       P., Archana Jorige and Vijaya Bhargavi, M.8, (12), 43668-43670, 2016.( Impact factor – 0.553).
    6. Design, semisynthesis and cytotoxic activity of novel ester derivatives of betulinic acid-1,2,4-oxadiazoles.    Journal of Asian Natural Products Research, Volume 18, 2016. Krishna Challa, M   Vijaya Bhargavi, & G L David Krupadanam, pages 1158-1168, 17 Jun 2016. (Impact factor – 0.66).
    7. Synthesis and antimicrobial assessment of novel coumarins featuring 1,2,4-oxadiazole Challa Krishna, Vijaya Bhargavi,Ch.Prasad Rao, G.L. David Krupadanam, Medicinal Chemistry   Research 24(10), October 2015, 3743–3751 (Impact factor – 1.23).
    8. Multidrug resistance in Tuberculosis: An overview by Vijayabhargavi in International Journal of Pharmaceutical and Phytopharmacological Research 2014; 4(3): 157-163.(Indexed in         Thomson Reuters – Web of Science, Elsevier (SCOPUS) ).
    9. Studies on production, purification, and molecular characterization of polygalacturonase from   Bacillus subtilis by M.P.Kusuma and Vijaya Bhargavi in European Journal of Biotechnology         and Bioscience 2014; 1(5): 1-6.
    10. Retinoids: An overview of clinical applications in Dermatology by Archana J and Vijaya M, Journal of Pharmaceutical Sciences and Research, Vol.2 (7), 2010, 376-383 ( Impact factor – 0.59).